Invivoscribe is the industry pioneer in Improving Lives with Precision Diagnostics®. It is considered as the foremost expert in providing molecular products and services for oncology testing.
Invivoscribe offers a full range of oncology testing products and services (B- and T-cell clonality, NGS gene panels, MRD assays, and comprehensive bioinformatics software), all developed under ISO 13485 design control and manufactured in our cGMP facility.
Invivoscribe offers clinical laboratories, pharmaceutical companies, physicians, patients, and researchers high-quality, reliable, and innovative molecular diagnostic solutions. These solutions range from CDx biomarker identification and patient stratification to assay development and reagent manufacturing to the commercialization of these assays either as services at their harmonized clinical laboratories or as kits available to laboratories in over 160 countries.
